Bausch Health Companies Inc logo

Bausch Health Companies Inc

TSX:BHC (Canada)  
C$ 12.70 (+1.93%) Mar 18
At Loss
Market Cap:
C$ 4.64B ($ 3.43B)
Enterprise V:
C$ 33.65B ($ 24.86B)
Volume:
398.98K
Avg Vol (2M):
306.89K
Also Trade In:
Volume:
398.98K
At Loss
Avg Vol (2M):
306.89K

Business Description

Description
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Name Current Vs Industry Vs History
Cash-To-Debt 0.04
Equity-to-Asset -0.04
Debt-to-Equity -21.91
Debt-to-EBITDA 10.14
Interest Coverage 1.2
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.07
Distress
Grey
Safe
Beneish M-Score -2.57
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 63.68
9-Day RSI 60.33
14-Day RSI 60.68
6-1 Month Momentum % 1.59
12-1 Month Momentum % 9.96

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.3
Quick Ratio 0.94
Cash Ratio 0.22
Days Inventory 181.96
Days Sales Outstanding 76.56
Days Payable 82.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.9
Shareholder Yield % -11.97

Financials (Next Earnings Date:2024-05-03 Est.)

TSX:BHC's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Bausch Health Companies Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 11,797.862
EPS (TTM) (C$) -2.202
Beta 0.25
Volatility % 44.4
14-Day RSI 60.68
14-Day ATR (C$) 0.365421
20-Day SMA (C$) 12.4815
12-1 Month Momentum % 9.96
52-Week Range (C$) 7.56 - 13.53
Shares Outstanding (Mil) 365.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bausch Health Companies Inc Filings

Filing Date Document Date Form
No Filing Data

Bausch Health Companies Inc Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Bausch Health Companies Inc Frequently Asked Questions

What is Bausch Health Companies Inc(TSX:BHC)'s stock price today?
The current price of TSX:BHC is C$12.70. The 52 week high of TSX:BHC is C$13.53 and 52 week low is C$7.56.
When is next earnings date of Bausch Health Companies Inc(TSX:BHC)?
The next earnings date of Bausch Health Companies Inc(TSX:BHC) is 2024-05-03 Est..
Does Bausch Health Companies Inc(TSX:BHC) pay dividends? If so, how much?
Bausch Health Companies Inc(TSX:BHC) does not pay dividend.

Press Release

Subject Date
No Press Release